Weighted-Average Shares Outstanding (Diluted): The number of shares held by shareholders including insiders but not including a company's treasury shares assuming conversion of all convertible debt, securities, warrants and options, sourced from the company 10-K or 10-Q SEC reports.
Trevi Therapeutics, Inc. (TRVI) had Weighted-Average Shares Outstanding (Diluted) of 145.10M for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
-- |
|
$-11.80M |
|
-- |
|
-- |
|
$13.92M |
|
$-13.92M |
|
$2.10M |
|
$-11.82M |
|
$-11.82M |
|
$-11.80M |
|
$-11.80M |
|
$-11.80M |
|
$-11.80M |
|
$-13.92M |
|
$-13.88M |
|
145.10M |
|
|
Weighted-Average Shares Outstanding (Diluted) |
145.10M |
$-0.08 |
|
$-0.08 |
|
| Balance Sheet Financials | |
$198.30M |
|
$0.21M |
|
$1.06M |
|
$199.36M |
|
$9.04M |
|
-- |
|
$0.53M |
|
$9.57M |
|
$189.79M |
|
$189.79M |
|
$189.79M |
|
128.22M |
|
| Cash Flow Statement Financials | |
$-34.46M |
|
$-63.50M |
|
$120.73M |
|
$34.10M |
|
$56.87M |
|
$22.77M |
|
$3.83M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
21.93 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-34.47M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-6.22% |
|
-6.22% |
|
-5.92% |
|
-6.22% |
|
$1.48 |
|
$-0.24 |
|
$-0.24 |
|